Bain Capital Life Sciences Opportunities IV, L.P.

13D and 13G Filings

13D/G filings
13G on 2 securities
CIK
0002015553
All SEC filings
View on sec.gov
Issuer % of Class Filed
ADC Therapeutics SA 13G
ADCT · H0036K147
10.0% 10/29/2026
Event 10/22/2026
Olema Pharmaceuticals, Inc. 13G/A Amendment 4
OLMA · 68062P106
8.2% 5/15/2026
Event 3/31/2026
Olema Pharmaceuticals, Inc. 13G/A Amendment 3
OLMA · 68062P106
10.0% 2/17/2026
Event 12/31/2025
Olema Pharmaceuticals, Inc. 13G/A Amendment 2
OLMA · 68062P106
10.0% 5/15/2025
Event 3/31/2025
Olema Pharmaceuticals, Inc. 13G/A Amendment 1
OLMA · 68062P106
10.0% 1/13/2025
Event 1/8/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.